150 related articles for article (PubMed ID: 21908159)
1. Association of rate-controlled persistent atrial fibrillation with clinical outcome and ventricular remodelling in recipients of cardiac resynchronization therapy.
Wilton SB; Kavanagh KM; Aggarwal SG; Philippon F; Yee R; Cowan K; Exner DV
Can J Cardiol; 2011; 27(6):787-93. PubMed ID: 21908159
[TBL] [Abstract][Full Text] [Related]
2. Impact of atrial fibrillation on improvement of functional mitral regurgitation in cardiac resynchronization therapy.
van der Bijl P; Vo NM; Leung M; Ajmone Marsan N; Delgado V; Stone GW; Bax JJ
Heart Rhythm; 2018 Dec; 15(12):1816-1822. PubMed ID: 30017815
[TBL] [Abstract][Full Text] [Related]
3. Determinants of New-Onset Atrial Fibrillation in Patients Receiving CRT: Mechanistic Insights From Speckle Tracking Imaging.
Sade LE; Atar I; Özin B; Yüce D; Müderrisoğlu H
JACC Cardiovasc Imaging; 2016 Feb; 9(2):99-111. PubMed ID: 26684972
[TBL] [Abstract][Full Text] [Related]
4. Atrial reverse remodelling is associated with outcome of cardiac resynchronization therapy.
Kloosterman M; Rienstra M; Mulder BA; Van Gelder IC; Maass AH
Europace; 2016 Aug; 18(8):1211-9. PubMed ID: 26718536
[TBL] [Abstract][Full Text] [Related]
5. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).
Gasparini M; Leclercq C; Lunati M; Landolina M; Auricchio A; Santini M; Boriani G; Lamp B; Proclemer A; Curnis A; Klersy C; Leyva F
JACC Heart Fail; 2013 Dec; 1(6):500-7. PubMed ID: 24622002
[TBL] [Abstract][Full Text] [Related]
6. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response.
Hwang JK; Gwag HB; Park KM; On YK; Kim JS; Park SJ
PLoS One; 2019; 14(1):e0210603. PubMed ID: 30633768
[TBL] [Abstract][Full Text] [Related]
8. Clinical and classic echocardiographic features of patients with, and without, left ventricle reverse remodeling following the introduction of cardiac resynchronization therapy.
Wiliński J; Czarnecka D; Wojciechowska W; Kloch-Badełek M; Jastrzębski M; Bacior B; Sondej T; Kusak P; Przybyła A; Kawecka-Jaszcz K
Cardiol J; 2011; 18(2):157-64. PubMed ID: 21432822
[TBL] [Abstract][Full Text] [Related]
9. A pilot study to assess benefit of atrial rhythm control after cardiac resynchronization therapy and atrioventricular node ablation.
Schwartzman D; Housel D; Bazaz R; Jain S; Saba S; Gorcsan J; Adelstein E
Pacing Clin Electrophysiol; 2015 Feb; 38(2):275-81. PubMed ID: 25431023
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm.
Jędrzejczyk-Patej E; Lenarczyk R; Pruszkowska P; Kowalski O; Mazurek M; Sokal A; Boidol J; Woźniak A; Pluta S; Szulik M; Liberska A; Kalarus Z
Cardiol J; 2014; 21(3):309-15. PubMed ID: 23990182
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis.
Wilton SB; Leung AA; Ghali WA; Faris P; Exner DV
Heart Rhythm; 2011 Jul; 8(7):1088-94. PubMed ID: 21338711
[TBL] [Abstract][Full Text] [Related]
12. Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy.
Borleffs CJ; Ypenburg C; van Bommel RJ; Delgado V; van Erven L; Schalij MJ; Bax JJ
Heart Rhythm; 2009 Mar; 6(3):305-10. PubMed ID: 19251202
[TBL] [Abstract][Full Text] [Related]
13. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).
Barsheshet A; Wang PJ; Moss AJ; Solomon SD; Al-Ahmad A; McNitt S; Foster E; Huang DT; Klein HU; Zareba W; Eldar M; Goldenberg I
J Am Coll Cardiol; 2011 Jun; 57(24):2416-23. PubMed ID: 21658562
[TBL] [Abstract][Full Text] [Related]
14. [Cardiac resynchronization therapy in patients with permanent atrial fibrillation].
Mareev IuV; Shitov VN; Kiktev VG; Sapel'nikov OV; Latypov RS; Grishin IR; Malkina TA; Nesterenko LIu; Iuricheva IuA; Sokolov SF; Saidova MA; Akchurin RS; Golitsyn SP
Kardiologiia; 2013; 53(5):43-9. PubMed ID: 23952994
[TBL] [Abstract][Full Text] [Related]
15. Improvement of left atrial function is associated with lower incidence of atrial fibrillation and mortality after cardiac resynchronization therapy.
Fung JW; Yip GW; Zhang Q; Fang F; Chan JY; Li CM; Wu LW; Chan GC; Chan HC; Yu CM
Heart Rhythm; 2008 Jun; 5(6):780-6. PubMed ID: 18467188
[TBL] [Abstract][Full Text] [Related]
16. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study).
Tolosana JM; Hernandez Madrid A; Brugada J; Sitges M; Garcia Bolao I; Fernandez Lozano I; Martinez Ferrer J; Quesada A; Macias A; Marin W; Escudier JM; Gomez AA; Gimenez Alcala M; Tamborero D; Berruezo A; Mont L;
Am J Cardiol; 2008 Aug; 102(4):444-9. PubMed ID: 18678303
[TBL] [Abstract][Full Text] [Related]
17. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
Rönn F; Kesek M; Karp K; Henein M; Jensen SM
Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
[TBL] [Abstract][Full Text] [Related]
18. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
19. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy.
Dong K; Shen WK; Powell BD; Dong YX; Rea RF; Friedman PA; Hodge DO; Wiste HJ; Webster T; Hayes DL; Cha YM
Heart Rhythm; 2010 Sep; 7(9):1240-5. PubMed ID: 20156595
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Higher Frequency of Atrial Fibrillation in Patients with Cardiac Resynchronization Therapy.
Grbović A; Pavlović S; Žugić V
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
